Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

NCT02535611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Excitotoxicity
Memantine

Interventions

DRUG: Placebo
DRUG: Memantine

Sponsor

Mazandaran University of Medical Sciences